These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17521525)

  • 21. [Routine screening for microalbuminemia in type 2 diabetes mellitus--con].
    Sawicki PT
    Dtsch Med Wochenschr; 2003 May; 128(21):1188. PubMed ID: 12761693
    [No Abstract]   [Full Text] [Related]  

  • 22. [Routine screening for microalbuminemia in type 2 diabetes mellitus--pro].
    Dikow R; Ritz E
    Dtsch Med Wochenschr; 2003 May; 128(21):1187. PubMed ID: 12761692
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus.
    Araki S; Haneda M; Koya D; Kashiwagi A; Uzu T; Kikkawa R
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S54-8. PubMed ID: 18947896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Specifics of diabetic nephropathy, viewpoint in diabetology: trends of diabetic nephropathy in diabetes].
    Krempf M
    Nephrol Ther; 2006 May; 2 Suppl 3():S190-2. PubMed ID: 17370849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early diagnosis of diabetic nephropathy.
    Bilous RW
    Diabetes Metab Rev; 1996 Oct; 12(3):243-53. PubMed ID: 8959387
    [No Abstract]   [Full Text] [Related]  

  • 26. Initiation, progression and remission of diabetic nephropathy.
    Hovind P
    Dan Med Bull; 2005 Dec; 52(4):119-42. PubMed ID: 16764047
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Albuminuria in the diabetic patient: practical management].
    Kistler AD
    Praxis (Bern 1994); 2013 Oct; 102(20):1229-35. PubMed ID: 24088233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nephroprotection: how to slow the progression of chronic renal insufficiency?].
    Hannedouche T; Krummel T; Parvez-Braun L
    Nephrol Ther; 2005 May; 1(2):135-44. PubMed ID: 16895678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albuminuric and non-albuminuric pathways to renal impairment in diabetes.
    Macisaac RJ; Jerums G
    Minerva Endocrinol; 2005 Sep; 30(3):161-77. PubMed ID: 16208306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic nephropathy: introduction.
    Breyer MD
    Semin Nephrol; 2007 Mar; 27(2):129. PubMed ID: 17418681
    [No Abstract]   [Full Text] [Related]  

  • 32. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.
    Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA
    Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923
    [No Abstract]   [Full Text] [Related]  

  • 33. Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes.
    Earle KA; Harry D; Zitouni K
    Diabetes Res Clin Pract; 2008 Jan; 79(1):68-73. PubMed ID: 17766000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.
    Bakris GL
    Mayo Clin Proc; 2011 May; 86(5):444-56. PubMed ID: 21531886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic hypertension.
    Khan KA; Govindarajan G; Whaley-Connell A; Sowers JR
    Heart Fail Clin; 2006 Jan; 2(1):25-36. PubMed ID: 17386874
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic nephropathy in childhood and adolescents.
    Chiarelli F; Casani A; Tumini S; Kordonouri O; Danne T
    Diabetes Nutr Metab; 1999 Apr; 12(2):144-53. PubMed ID: 10554897
    [No Abstract]   [Full Text] [Related]  

  • 39. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.
    Rydén L; Waeber B; Ruilope LM; Mancia G; Volpe M; Holzgreve H; Mogensen CE; Laurent S
    Blood Press; 2008; 17(5-6):250-9. PubMed ID: 19012063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.